Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Breast Cancer

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 31 articles: HTML format Text format

Single Articles

October 2018
1. 
   Breast Cancer in Men.
   N Engl J Med. 2018;379:1385-1386.
   PubMed     Text format    
   
   
   
2. KANAKIS GA, Jorgensen N, Goulis DG
   Breast Cancer in Men.
   N Engl J Med. 2018;379:1385.
   PubMed     Text format    
   
   
   August 2018
3. LITTON JK, Rugo HS, Ettl J, Hurvitz SA, et al
   Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.
   N Engl J Med. 2018 Aug 15. doi: 10.1056/NEJMoa1802905.
   PubMed     Text format     Abstract available
   
   
   July 2018
4. STEARNS V
   TAILORing Adjuvant Systemic Therapy for Breast Cancer.
   N Engl J Med. 2018;379:191-192.
   PubMed     Text format    
   
   
   June 2018
5. GIORDANO SH
   Breast Cancer in Men.
   N Engl J Med. 2018;378:2311-2320.
   PubMed     Text format    
   
   
   
6. MULASI I
   The Scarlet Virus.
   N Engl J Med. 2018;378:2157-2159.
   PubMed     Text format    
   
   
   
7. FRANCIS PA, Pagani O, Fleming GF, Walley BA, et al
   Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.
   N Engl J Med. 2018 Jun 4. doi: 10.1056/NEJMoa1803164.
   PubMed     Text format     Abstract available
   
   
   
8. LIPPMAN ME
   Endocrine Adjuvant Therapy for Localized Breast Cancer.
   N Engl J Med. 2018 Jun 4. doi: 10.1056/NEJMe1806130.
   PubMed     Text format    
   
   
   
9. SPARANO JA, Gray RJ, Makower DF, Pritchard KI, et al
   Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.
   N Engl J Med. 2018 Jun 3. doi: 10.1056/NEJMoa1804710.
   PubMed     Text format     Abstract available
   
   
   May 2018
10. ELMORE SNC
    p53 and Me.
    N Engl J Med. 2018;378:1962-1963.
    PubMed     Text format    
    
    
    March 2018
11. NACHTIGALL L, Naftolin F, Keefe DL
    Contemporary Hormonal Contraception and the Risk of Breast Cancer.
    N Engl J Med. 2018;378:1265.
    PubMed     Text format    
    
    
    
12. CRAMER DW, Braaten K
    Contemporary Hormonal Contraception and the Risk of Breast Cancer.
    N Engl J Med. 2018;378:1264-8.
    PubMed     Text format    
    
    
    
13. ROBERTS K, Merkatz RB, Vieira CS
    Contemporary Hormonal Contraception and the Risk of Breast Cancer.
    N Engl J Med. 2018;378:1264.
    PubMed     Text format    
    
    
    
14. WOOD S
    Contemporary Hormonal Contraception and the Risk of Breast Cancer.
    N Engl J Med. 2018;378:1264.
    PubMed     Text format    
    
    
    
15. SCHWARZ EB, Foster DG, Grossman D
    Contemporary Hormonal Contraception and the Risk of Breast Cancer.
    N Engl J Med. 2018;378:1263-4.
    PubMed     Text format    
    
    
    
16. 
    Contemporary Hormonal Contraception and the Risk of Breast Cancer.
    N Engl J Med. 2018;378:1263-1266.
    PubMed     Text format    
    
    
    
17. 
    Breast-Cancer Recurrence after Stopping Endocrine Therapy.
    N Engl J Med. 2018;378:870-871.
    PubMed     Text format    
    
    
    
18. ANDERSON GM
    Breast-Cancer Recurrence after Stopping Endocrine Therapy.
    N Engl J Med. 2018;378:870.
    PubMed     Text format    
    
    
    January 2018
19. VAN DEN HEUVELEIBRINK MM, van der Kooi ALF, Wallace WHB
    Fertility Preservation in Women.
    N Engl J Med. 2018;378:399-400.
    PubMed     Text format    
    
    
    
20. DONNEZ J, Dolmans MM
    Fertility Preservation in Women.
    N Engl J Med. 2018;378:400-401.
    PubMed     Text format    
    
    
    December 2017
21. TURNER NC
    Signatures of DNA-Repair Deficiencies in Breast Cancer.
    N Engl J Med. 2017;377:2490-2492.
    PubMed     Text format    
    
    
    
22. MORCH LS, Skovlund CW, Hannaford PC, Iversen L, et al
    Contemporary Hormonal Contraception and the Risk of Breast Cancer.
    N Engl J Med. 2017;377:2228-2239.
    PubMed     Text format     Abstract available
    
    
    
23. DEMICHELE A, Yee D, Esserman L
    Mechanisms of Resistance to Neoadjuvant Chemotherapy in Breast Cancer.
    N Engl J Med. 2017;377:2287-2289.
    PubMed     Text format    
    
    
    
24. HUNTER DJ
    Oral Contraceptives and the Small Increased Risk of Breast Cancer.
    N Engl J Med. 2017;377:2276-2277.
    PubMed     Text format    
    
    
    November 2017
25. PAN H, Gray R, Braybrooke J, Davies C, et al
    20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.
    N Engl J Med. 2017;377:1836-1846.
    PubMed     Text format     Abstract available
    
    
    
26. NAROD S, Booth CM, Foulkes WD
    Olaparib for Metastatic Germline BRCA-Mutated Breast Cancer.
    N Engl J Med. 2017;377:1792.
    PubMed     Text format    
    
    
    
27. OIDE T, Mitsuishi T
    Pigmented Macule - A Skin Manifestation of Invasive Breast Cancer.
    N Engl J Med. 2017;377:1777.
    PubMed     Text format    
    
    
    
28. 
    Olaparib for Metastatic Germline BRCA-Mutated Breast Cancer.
    N Engl J Med. 2017;377:1792-3.
    PubMed     Text format    
    
    
    
29. GREENE AK, Voss SD, Maclellan RA
    Liposuction for Swelling in Patients with Lymphedema.
    N Engl J Med. 2017;377:1788-1789.
    PubMed     Text format    
    
    
    October 2017
30. LEMERY S, Keegan P, Pazdur R
    First FDA Approval Agnostic of Cancer Site - When a Biomarker Defines the Indication.
    N Engl J Med. 2017;377:1409-1412.
    PubMed     Text format    
    
    
    September 2017
31. RAMASWAMI R, Morrow M, Jagsi R
    Contralateral Prophylactic Mastectomy.
    N Engl J Med. 2017;377:1288-1291.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: